Literature DB >> 19531770

Differential repetitive DNA methylation in multiple myeloma molecular subgroups.

Valentina Bollati1, Sonia Fabris, Valeria Pegoraro, Domenica Ronchetti, Laura Mosca, Giorgio Lambertenghi Deliliers, Valeria Motta, Pier Alberto Bertazzi, Andrea Baccarelli, Antonino Neri.   

Abstract

Multiple myeloma (MM) is characterized by a wide spectrum of genetic changes. Global hypomethylation of repetitive genomic sequences such as long interspersed nuclear element 1 (LINE-1), Alu and satellite alpha (SAT-alpha) sequences has been associated with chromosomal instability in cancer. Methylation status of repetitive elements in MM has never been investigated. In the present study, we used a quantitative bisulfite-polymerase chain reaction pyrosequencing method to evaluate the methylation patterns of LINE-1, Alu and SAT-alpha in 23 human myeloma cell lines (HMCLs) and purified bone marrow plasma cells from 53 newly diagnosed MM patients representative of different molecular subtypes, 7 plasma cell leukemias (PCLs) and 11 healthy controls. MMs showed a decrease of Alu [median: 21.1 %5-methylated cytosine (%5mC)], LINE-1 (70.0%5mC) and SAT-alpha (77.9%5mC) methylation levels compared with controls (25.2, 79.5and 89.5%5mC, respectively). Methylation levels were lower in PCLs and HMCLs compared with MMs (16.7 and 14.8%5mC for Alu, 45.5 and 42.4%5mC for LINE-1 and 33.3 and 43.3%5mC for SAT-alpha, respectively). Notably, LINE-1 and SAT-alpha methylation was significantly lower in the non-hyperdiploid versus hyperdiploid MMs (P = 0.01 and 0.02, respectively), whereas Alu and SAT-alpha methylation was significantly lower in MMs with t(4;14) (P = 0.02 and 0.004, respectively). Finally, we correlated methylation patterns with DNA methyltransferases (DNMTs) messenger RNA levels showing in particular a progressive and significant increase of DNMT1 expression from controls to MMs, PCLs and HMCLs (P < 0.001). Our results indicate that global hypomethylation of repetitive elements is significantly associated with tumor progression in MM and may contribute toward a more extensive stratification of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531770     DOI: 10.1093/carcin/bgp149

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  43 in total

1.  Associations of LINE-1 DNA Methylation with Preterm Birth in a Prospective Cohort Study.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Andrea Baccarelli; Letizia Tarantini; Caroline E Boeke; Ken Kleinman; Augusto A Litonjua; Janet W Rich-Edwards; Matthew W Gillman
Journal:  J Dev Orig Health Dis       Date:  2012-06       Impact factor: 2.401

2.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

Review 3.  Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Authors:  Daphné Dupéré-Richer; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

Review 4.  Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis.

Authors:  Mark C Wilkes; Claire E Repellin; Kathleen M Sakamoto
Journal:  Mol Genet Metab       Date:  2017-07-25       Impact factor: 4.797

5.  DNA methylation variation of human-specific Alu repeats.

Authors:  Arundhati Bakshi; Scott W Herke; Mark A Batzer; Joomyeong Kim
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

Review 6.  The transcript repeat element: the human Alu sequence as a component of gene networks influencing cancer.

Authors:  Paula Moolhuijzen; Jerzy K Kulski; David S Dunn; David Schibeci; Roberto Barrero; Takashi Gojobori; Matthew Bellgard
Journal:  Funct Integr Genomics       Date:  2010-08       Impact factor: 3.410

7.  Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.

Authors:  Jeffrey R Sawyer; Erming Tian; Christoph J Heuck; Donald J Johann; Joshua Epstein; Charles M Swanson; Janet L Lukacs; Regina Lichti Binz; Marian Johnson; Gael Sammartino; Maurizio Zangari; Faith E Davies; Frits van Rhee; Gareth J Morgan; Bart Barlogie
Journal:  Blood       Date:  2015-05-05       Impact factor: 22.113

8.  Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma.

Authors:  Jorge García Martínez; Jhudit Pérez-Escuredo; Patricia Castro-Santos; César Alvarez Marcos; José Luis Llorente Pendás; Mario F Fraga; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2012-06-21       Impact factor: 6.730

9.  MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples.

Authors:  Karolina A Aberg; Joseph L McClay; Srilaxmi Nerella; Lin Y Xie; Shaunna L Clark; Alexandra D Hudson; Jozsef Bukszár; Daniel Adkins; Christina M Hultman; Patrick F Sullivan; Patrik K E Magnusson; Edwin J C G van den Oord
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

Review 10.  Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors:  C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal:  Leukemia       Date:  2012-11-21       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.